Screener
Maravai LifeSciences Holdings, Inc. MRVI TriLink — Cost of revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $51,442 | $47,397 | $117,279 | $94,247 |
| Cost of revenue | 30,792 | 39,629 | 62,928 | 78,754 |
| Gross profit | 20,650 | 7,768 | 54,351 | 15,493 |
| Operating expenses: | ||||
| Selling, general and administrative | 32,070 | 38,715 | 61,162 | 78,279 |
| Research and development | 3,702 | 4,882 | 7,591 | 9,770 |
| Goodwill impairment | — | 30,449 | — | 42,884 |
| Restructuring | (33) | — | 2,845 | — |
Item 1. Financial Statements
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s trilink — cost of revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — cost of revenue of $18.32M in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s trilink — cost of revenue changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s trilink — cost of revenue decreased by 24.9% year-over-year, from $24.41M to $18.32M.
- What does trilink — cost of revenue mean?
- This represents the direct costs attributable to the production of goods and services sold by the segment, including raw materials, labor, and manufacturing overhead. It is a fundamental measure of the segment's gross margin efficiency and production cost control.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude